cbdMD (YCBD) Accounts Payables (2016 - 2025)
cbdMD (YCBD) reported Accounts Payables of $880978.0 for Q4 2025, down 24.13% on a YoY basis from $1.2 million in Q4 2024, and down 24.94% sequentially from $1.2 million in Q3 2025.
cbdMD (YCBD) Accounts Payables (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Accounts Payables data on file, last reported at $880978.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables fell 24.13% year-over-year to $880978.0; the trailing twelve-month figure through Dec 2025 stood at $880978.0 (down 24.13% YoY), and the FY2025 full-year result was $1.2 million, down 23.84% from the prior year.
- Accounts Payables eased to $880978.0 in Q4 2025, from $1.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $3.7 million in Q4 2021 to a low of $880978.0 in Q4 2025.
- A 5-year average of $1.9 million and a median of $1.6 million in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables soared 72.28% in 2021 and plunged 54.01% in 2022, its largest moves.
- Tracing YCBD's Accounts Payables over 5 years: stood at $3.7 million in 2021, then slumped by 54.01% to $1.7 million in 2022, then fell by 7.27% to $1.6 million in 2023, then fell by 25.88% to $1.2 million in 2024, then dropped by 24.13% to $880978.0 in 2025.
- Business Quant data shows YCBD's Accounts Payables at $880978.0 in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 880,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 880,978.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 3.67 Mn |
| Sep 30, 2021 | 2.98 Mn |
| Jun 30, 2021 | 3.14 Mn |
| Mar 31, 2021 | 2.84 Mn |